Stevanato Group S.p.A.

Healthcare

NYSE:STVN · New York Stock Exchange

Market Cap $4.72B Beta 0.78 P/E (TTM) 28.6

$17.08 -1.16%

-$0.20 today

52W Low $12.89High $28.00

Vol 0.49M · Avg 0.51M

EPS (TTM)$0.52

Div Yield0.36%

Medical - Instruments & Supplies

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-27.01%

Period High

$27.85

Period Low

$13.38

Latest

$17.08

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Axsome Therapeutics, Inc.

NASDAQ:AXSM

$13.13B

BrightSpring Health Services, Inc. Common Stock

NASDAQ:BTSG

$12.26B

Masimo Corporation

NASDAQ:MASI

$9.42B

Nuvalent, Inc.

NASDAQ:NUVL

$9.07B

AptarGroup, Inc.

NYSE:ATR

$7.51B

Avantor, Inc.

NYSE:AVTR

$6.41B

Teleflex Incorporated

NYSE:TFX

$5.78B

Chemed Corporation

NYSE:CHE

$5.56B

Bausch + Lomb Corporation

NYSE:BLCO

$5.38B

Merit Medical Systems, Inc.

NASDAQ:MMSI

$3.97B

What is the latest STVN filing?

The latest filing shown is 6-K dated Jun 5, 2026.

How many recent filings does STVN have?

Intrinsic Alpha currently shows 20 recent filings for STVN.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.